Yue Lu

Yue Lu

Auto-generated profile, based on publicly available information

Yue Lu

Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT 84112, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2018 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
JYJunjie Yan
Junjie Yan
YLYue Lu
Yue Lu
GCGuojun Chen
Guojun Chen
MYMin Yang
Min Yang
ZGZhen Gu
Zhen Gu
This tutorial review summarizes the common performances, featured properties and various state-of-the-art biomedical applications of liquid metals.

14 December 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
SKSuman Kumari
Suman Kumari
CLChristopher Lausted
Christopher Lausted
KSKelsey Scherler
Kelsey Scherler
ANAlphonsus Ng
Alphonsus Ng
YLYue Lu
Yue Lu
KWKai Wang
Kai Wang
Extracellular vesicles (EVs) are lipid bilayer nanoparticles released from all known cells and are involved in cell-to-cell communication via their molecular content. EVs have been found in all tissues and body fluids, carrying a variety of biomolecules, including DNA, RNA, proteins, metabolites, and lipids, offering insights into cellular and pathophysiological conditions. Despite the emergence of EVs and their molecular contents as important biological indicators, it remains difficult to explore EV-mediated biological processes due to their small size and heterogeneity and the technical challenges in characterizing their molecular content. EV-associated small RNAs, especially microRNAs, have been extensively studied. However, other less characterized RNAs, including protein-coding mRNAs, long noncoding RNAs, circular RNAs, and tRNAs, have also been found in EVs. Furthermore, the EV-associated proteins can be used to distinguish different types of EVs. The spectrum of EV-associated RNAs, as well as proteins, may be associated with different pathophysiological conditions. Therefore, the ability to comprehensively characterize EVs’ molecular content is critical for understanding their biological function and potential applications in disease diagnosis. Here, we set out to provide an overview of EV-associated RNAs and proteins as well as approaches currently being used to characterize them.

21 October 2014 in Chemical Communications
Verified
Journal Article
Open access
PDF file
YLYue Lu
Yue Lu
RMRan Mo
Ran Mo
WTWanyi Tai
Wanyi Tai
WSWujin Sun
Wujin Sun
DPDennis B. Pacardo
Dennis B. Pacardo
ZGZhen Gu
Zhen Gu
Self-folded redox/acid dual-responsive nanocarriers (RAD-NCs) are developed for physiologically triggered delivery of anticancer drugs. The evidenced redox/acid responsiveness, facile decoration of ligands, and active tumor-targeting capability of RAD-NCs suggest their potential as a promising formulation for tumor-targeted chemotherapy.

4 October 2023 in Cell Reports
Verified
Journal Article
Open access
ANAlphonsus H.C. Ng
Alphonsus H.C. Ng
HHHuiqian Hu
Huiqian Hu
KWKai Wang
Kai Wang
KSKelsey Scherler
Kelsey Scherler
SWSarah E. Warren
Sarah E. Warren
JHJames R. Heath
James R. Heath
Local immune activation at mucosal surfaces, mediated by mucosal lymphoid tissues, is vital for effective immune responses against pathogens. While pathogens like severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can spread to multiple organs, patients with coronavirus disease 2019 (COVID-19) primarily experience inflammation and damage in their lungs. To investigate this apparent organ-specific immune response, we develop an analytical framework that recognizes the significance of mucosal lymphoid tissues. This framework combines histology, immunofluorescence, spatial transcript profiling, and mathematical modeling to identify cellular and gene expression differences between the lymphoid tissues of the lung and the gut and predict the determinants of those differences. Our findings indicate that mucosal lymphoid tissues are pivotal in organ-specific immune response to SARS-CoV-2, mediating local inflammation and tissue damage and contributing to immune dysfunction. The framework developed here has potential utility in the study of long COVID and may streamline biomarker discovery and treatment design for diseases with differential pathologies at the organ level.

30 January 2026 in Med
Verified
Journal Article
Closed access
HHHuiqian Hu
Huiqian Hu
HZHuanbin Zhao
Huanbin Zhao
PLPing Lu
Ping Lu
TMTeng Ma
Teng Ma
SYSatoshi Yoshimura
Satoshi Yoshimura
YLYue Lu
Yue Lu

18 September 2026 in STAR Protocols
Verified
Journal Article
Open access
HHHuiqian Hu
Huiqian Hu
ANAlphonsus H.C. Ng
Alphonsus H.C. Ng
YLYue Lu
Yue Lu